Patients | Controls | P Value | |
---|---|---|---|
N | 13 | 15 | |
Age | 59.72 ± 7.72 | 57.45 ± 10.34 | NS |
Sex (% male) | 62 | 47 | NS |
CNS | 9.85 ± 3.72 | 0.33 ± 0.62 | <.0001 |
MMSE | 25.22 ± 3.11 | 28.50 ± 1.62 | <.005 |
Note:—CNS indicates Clinical Neurological Scale; MMS, Mini-Mental State Examination; NS, not significant.
a Significant differences between the groups were assessed by t test for continuous measures and χ2 for gender distributions. Symptom severity was quantified by the CNS12 and MMS.11